Showing results (2201-2210 of 4,583) with videos related to

Sort By:
Pageof 459
Experimental Dermatology|August 4, 2023
Increased formation of neutrophil extracellular traps induced by autophagy and identification of autophagy-related biomarkers in systemic lupus erythematosusMingfang Li, Luobei Weng, Datang Yu, et al.
Experimental Dermatology|August 7, 2023
Far-UVC- and UVB-induced DNA damage depending on skin typeLoris Busch, Marius Kröger, Daniela F Zamudio Díaz, et al.
Experimental Dermatology|August 8, 2023
Genome-wide association studies in the Japanese population identified genetic loci and target gene associated with epidermal turnoverRyosuke Okuno, Yu Inoue, Yuichi Hasebe, et al.
Experimental Dermatology|August 22, 2023
Requisite instruments for the establishment of three-dimensional epidermal human skin equivalents-A methods reviewChristianna Marie Czyz, Paul Werner Kunth, Florian Gruber, et al.
Experimental Dermatology|September 9, 2023
Nuclear translocation of PKM2 mediates keratinocyte metabolic reprogramming in psoriasisLuting Yang, Jie Zhang, Chunqing Hu, et al.
Experimental Dermatology|September 4, 2023
A loss-of-function NCSTN mutation associated with familial Dowling Degos disease and hidradenitis suppurativaAna Sofia Lima Estevao de Oliveira, Roberta Cardoso de Siqueira, Cécile Nait-Meddour, et al.
Experimental Dermatology|August 28, 2023
Elevated serum fibrinogen levels in Chinese patients with minor recurrent aphthous stomatitis: An observational studyHui Yao, Yiwen Deng, Guanhuan Du, et al.
Experimental Dermatology|June 26, 2023
Topical metformin 30% gel in the treatment of acne vulgaris in women, a split face, placebo-controlled studyMohamed H M El-Komy, Nesma Moustafa Kamel Abdo, Rehab Nabil Shamma, et al.
Experimental Dermatology|June 26, 2023
Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitisA Chiricozzi, L Di Nardo, N Gori, et al.
Experimental Dermatology|June 13, 2023
Topical N-phosphonacetyl-l-aspartate is a dual action candidate for treating non-melanoma skin cancerKala K Mahen, Lilian Markley, Jolie Bogart, et al.
Pageof 459